Belgium vs Bosnia and Herzegovina: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
Bosnia and Herzegovina
255
in 2021
Belgium rank
86th
Bosnia and Herzegovina rank
89th
The number of people with susceptibility test result for rifampicin over time
- Belgium
- Bosnia and Herzegovina
How they compare
Belgium currently reports 377 against 255 in Bosnia and Herzegovina, a difference of 122.
That makes Belgium's figure about 1.5 times Bosnia and Herzegovina's.
Across all 5 years both countries report, Belgium has been ahead every year.
Belgium ranks 86th and Bosnia and Herzegovina ranks 89th of 155 countries.
Belgium has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 362 | 68 | Belgium |
| 2020s | 348.5 | 231.5 | 117 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or Bosnia and Herzegovina?
- Belgium, at 377 against 255 in Bosnia and Herzegovina as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and Bosnia and Herzegovina?
- 122, with Belgium ahead.
- How many years of comparable data are there for Belgium and Bosnia and Herzegovina?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and Bosnia and Herzegovina rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and Bosnia and Herzegovina ranks 89th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.